Last reviewed · How we verify
hBMMSC
At a glance
| Generic name | hBMMSC |
|---|---|
| Also known as | human Bone Marrow Mesenchymal Stem Cell |
| Sponsor | Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder (PHASE1)
- Study of Human Bone Marrow Mesenchymal Stem Cells in APAP (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- hBMMSC CI brief — competitive landscape report
- hBMMSC updates RSS · CI watch RSS
- Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. portfolio CI